These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

986 related items for PubMed ID: 15657388

  • 1. Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society.
    Knight BP, Gersh BJ, Carlson MD, Friedman PA, McNamara RL, Strickberger SA, Tse HF, Waldo AL, American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias), Quality of Care and Outcomes Research Interdisciplinary Working Group, Heart Rhythm Society, AHA Writing Group.
    Circulation; 2005 Jan 18; 111(2):240-3. PubMed ID: 15657388
    [Abstract] [Full Text] [Related]

  • 2. Pacing for the prevention of atrial fibrillation.
    Gillis AM, Kerr CR, Crystal E.
    Can J Cardiol; 2005 Sep 18; 21 Suppl B():41B-44B. PubMed ID: 16239987
    [Abstract] [Full Text] [Related]

  • 3. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
    Kantharia BK, Freedman RA, Hoekenga D, Tomassoni G, Worley S, Sorrentino R, Steinhaus D, Wolkowicz JM, Syed ZA, AOP Study Investigators.
    Europace; 2007 Nov 18; 9(11):1024-30. PubMed ID: 17913697
    [Abstract] [Full Text] [Related]

  • 4. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL, Dual Chamber and VVI Implantable Defibrillator trial investigators.
    Card Electrophysiol Rev; 2003 Dec 18; 7(4):468-72. PubMed ID: 15071277
    [Abstract] [Full Text] [Related]

  • 5. The role of pacemaker therapy in the prevention of atrial fibrillation.
    Delfaut P, Prakash A, Giorgberidze I, Munsif AN, Mathew PP, Krol RB, Saksena S.
    Semin Interv Cardiol; 1997 Dec 18; 2(4):219-25. PubMed ID: 9704356
    [Abstract] [Full Text] [Related]

  • 6. [The role of permanent pacing in atrial fibrillation].
    Kargul W, Młynarski R, Chudzik M.
    Wiad Lek; 2006 Dec 18; 59(5-6):368-71. PubMed ID: 17017484
    [Abstract] [Full Text] [Related]

  • 7. A novel method of multisite atrial pacing, incorporating Bachmann's bundle area and coronary sinus ostium, for electrical atrial resynchronization in patients with recurrent atrial fibrillation.
    Lewicka-Nowak E, Kutarski A, Dabrowska-Kugacka A, Rucinski P, Zagozdzon P, Raczak G.
    Europace; 2007 Sep 18; 9(9):805-11. PubMed ID: 17670780
    [Abstract] [Full Text] [Related]

  • 8. Septal atrial pacing for the prevention of atrial fibrillation.
    Hakacova N, Velimirovic D, Margitfalvi P, Hatala R, Buckingham TA.
    Europace; 2007 Dec 18; 9(12):1124-8. PubMed ID: 18024494
    [Abstract] [Full Text] [Related]

  • 9. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study.
    Sulke N, Silberbauer J, Boodhoo L, Freemantle N, Kamalvand K, O'Nunain S, Hildick-Smith D, Lloyd GW, Patel NR, Paul V.
    Europace; 2007 Sep 18; 9(9):790-7. PubMed ID: 17562750
    [Abstract] [Full Text] [Related]

  • 10. Dynamic and dual-site atrial pacing in the prevention of atrial fibrillation: The STimolazione Atrial DInamica Multisito (STADIM) Study.
    De Simone A, Senatore G, Donnici G, Turco P, Romano E, Gazzola C, Stabile G.
    Pacing Clin Electrophysiol; 2007 Jan 18; 30 Suppl 1():S71-4. PubMed ID: 17302722
    [Abstract] [Full Text] [Related]

  • 11. ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT).
    Hohnloser SH, Capucci A, Fain E, Gold MR, van Gelder IC, Healey J, Israel CW, Lau CP, Morillo C, Connolly SJ, ASSERT Investigators and Committees.
    Am Heart J; 2006 Sep 18; 152(3):442-7. PubMed ID: 16923410
    [Abstract] [Full Text] [Related]

  • 12. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L, Muto C, Maounis T, Schuchert A, Bongiorni MG, Frank R, Vesterlund T, Brachmann J, Vicentini A, Jauvert G, Tadeo G, Gras D, Lisi F, Dello Russo A, Rey JL, Boulogne E, Ricciardi G, Management of Atrial fibrillation Suppression in AF-HF COmorbidity Therapy Study Group.
    Am Heart J; 2008 Sep 18; 156(3):520-6. PubMed ID: 18760135
    [Abstract] [Full Text] [Related]

  • 13. Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study.
    Camm AJ, Sulke N, Edvardsson N, Ritter P, Albers BA, Ruiter JH, Lewalter T, Capucci PA, Hoffmann E, AFTherapy Investigators.
    Europace; 2007 Dec 18; 9(12):1110-8. PubMed ID: 18042619
    [Abstract] [Full Text] [Related]

  • 14. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.
    Padeletti L, Pürerfellner H, Mont L, Tukkie R, Manolis AS, Ricci R, Inama G, Serra P, Scheffer MG, Martins V, Warman EN, Vimercati M, Grammatico A, Boriani G, MINERVA Investigators.
    Heart Rhythm; 2015 Aug 18; 12(8):1717-25. PubMed ID: 25869753
    [Abstract] [Full Text] [Related]

  • 15. [Cardiac pacing for the prevention of atrial fibrillation. A current review].
    Yang A, Bitzen A, Schwab JO, Schrickel J, Lüderitz B, Lewalter T.
    Herz; 2005 Dec 18; 30(8):733-42. PubMed ID: 16331369
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias.
    Funck RC, Boriani G, Manolis AS, Püererfellner H, Mont L, Tukkie R, Pisapia A, Israel CW, Grovale N, Grammatico A, Padeletti L, MINERVA Study Group.
    Am Heart J; 2008 Sep 18; 156(3):445-51. PubMed ID: 18760124
    [Abstract] [Full Text] [Related]

  • 18. Pacing delivered rate and rhythm control for atrial fibrillation.
    Redfearn DP, Yee R.
    Curr Opin Cardiol; 2006 Mar 18; 21(2):83-7. PubMed ID: 16470140
    [Abstract] [Full Text] [Related]

  • 19. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.
    Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, Lamas GA, MOde Selection Trial Investigators.
    Circulation; 2003 Jun 17; 107(23):2932-7. PubMed ID: 12782566
    [Abstract] [Full Text] [Related]

  • 20. Atrial septal pacing: a new approach to prevent atrial fibrillation.
    Padeletti L, Michelucci A, Pieragnoli P, Colella A, Musilli N.
    Pacing Clin Electrophysiol; 2004 Jun 17; 27(6 Pt 2):850-4. PubMed ID: 15189515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.